| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 12/02/2004 | US20040241871 Using gel permeation and gas chromatography to identify modulators of endrocrine activities; detecting compounds which may be endrocrine health insults |
| 12/02/2004 | US20040241869 Multicompartment device for monitoring temperature changes in chemical and biochemical reactions; noninvasive electrothermometry; screening, identifying, and ranking drug candidates |
| 12/02/2004 | US20040241868 Apparatus which utilizes ultraviolet radiation pulses to assay and determine concentration of nitrogen dioxide, nitrogen monoxide and ozone in an air sample; pollution control |
| 12/02/2004 | US20040241867 Method of analyzing a wafer for metal impurities |
| 12/02/2004 | US20040241863 Method and apparatus for determination of water and for normal phase liquid chromatography |
| 12/02/2004 | US20040241858 Diagnosing cardiovascular and/or antiphospholipid disorders via presence of cholesterol/beta glycoprotein complexes in blood; bioassay; kits; solid phase synthesis |
| 12/02/2004 | US20040241853 Introducing one or more mutations into a template double-stranded polynucleotide via hybridization, replication and amplification of random genomic double stranded and heterozygous oligonucleotides sequences; genomics and directed evolution |
| 12/02/2004 | US20040241850 Glucosyltransferases which glucosylate abscisic acid |
| 12/02/2004 | US20040241848 Method of detecting microorgan ISMS using labelled electron acceptors |
| 12/02/2004 | US20040241840 Compositions for therapy |
| 12/02/2004 | US20040241834 Concentration of protein and/or peptides samples |
| 12/02/2004 | US20040241828 Automated process for detecting pathogenic organisms in water |
| 12/02/2004 | US20040241826 Mycobacterial antigens expressed during latency |
| 12/02/2004 | US20040241825 Methods for generating libraries of therapeutic bacteriophages having desired safety characteristics and methods for labeling and monitoring bacteriophages |
| 12/02/2004 | US20040241824 Identifying nucleotide sequences polymorphisms and/orvariations between methicillin resistant and sensitive bacteria; diagnosis and treatment of infection; using polymorphic sequences to distinguish between bacterial phenotypes; genomics |
| 12/02/2004 | US20040241823 Method and kit for the diagnosis of ulcerative colitis |
| 12/02/2004 | US20040241818 Assay |
| 12/02/2004 | US20040241805 Cell surface binding protein for use in treatment, diagnosis and prevention of cancer, inflammation, autoimmunity, allergy, asthma and nervous system disorders |
| 12/02/2004 | US20040241803 25 human secreted proteins |
| 12/02/2004 | US20040241794 Isolated human drug-metabolizing proteins , nucleic acid molecules encoding these drug- metabolizing proteins, and uses thereof |
| 12/02/2004 | US20040241792 Substrates and assays for beta-secretase |
| 12/02/2004 | US20040241791 Protein hydrolysates enriched in peptides having a carboxy terminal proline residue |
| 12/02/2004 | US20040241788 Methods and compositions for the detection of microbial contaminants |
| 12/02/2004 | US20040241784 Method of selecting non-pathogenic gram-positive lactic acid bacteria strains |
| 12/02/2004 | US20040241782 Methods and means for detecting enzymatic cleavage and linkage reactions |
| 12/02/2004 | US20040241779 comprises strip containing two pads positioned on adhesive backing for receiving samples; high speed; for analyzing glucose-6-phosphate dehydrogenase activity |
| 12/02/2004 | US20040241778 Novel polypeptide |
| 12/02/2004 | US20040241776 Multiplex enzyme-linked immunosorbent assay for detecting multiple analytes |
| 12/02/2004 | US20040241775 Methods and kits for determining risk of pre-term delivery |
| 12/02/2004 | US20040241774 Bioassay which utilizes cystatin c concentration to detect diabetic nephropathy; immunoassay |
| 12/02/2004 | US20040241770 Classifying erythrocytes comprising; obtain cells incubate with fluorescent dyes, recover cells, incubate with nuclear stain, monitor variation in signal intensity in cell population; flow cytometry |
| 12/02/2004 | US20040241769 Stromalysis reagent comprises dodecyl, tetradecyl and hexadecyl and/or trialkylammonium halide salts, and blood diluted with electroconductive isotonically balanced diluent; for positioning/determination of lymphoid and myeloid cells within automatic hematology analyzers; cell differentiation kits |
| 12/02/2004 | US20040241768 Quencher (Q), tethering element (T), and ligand (L); ligand binds biomolecule and separates from fluoropolymer (polyelectrolytes), creating detectable fluorescence; peptide nucleic acids; fluorescent dyes; bioassays; kits; solid phase synthesis |
| 12/02/2004 | US20040241767 Using filaggrin concentration in bodily fluids to diagnose arthritic disorders; immunoassay |
| 12/02/2004 | US20040241766 Carbamazepine assay |
| 12/02/2004 | US20040241765 Membrane receptor reagent and assay |
| 12/02/2004 | US20040241764 Using epstein barr virus-transformed donor lymphocytes immobilized on assay plates to detect immunological response to cardiac tissue graft; diagnosing/prognosing tissue rejection; immunoassay |
| 12/02/2004 | US20040241763 Detecting autoimmune and nervous system disfunction via ratio between glycans and immunoglobulin binding agent |
| 12/02/2004 | US20040241762 Assessing neuronal damage from blood samples |
| 12/02/2004 | US20040241761 Using human estrogen receptor gene expression as diagnostic indicator of diabetes; antidiabetic agents |
| 12/02/2004 | US20040241760 Kinesin-like proteins and methods of use |
| 12/02/2004 | US20040241759 Using encapsulated cells as diagnostic tools for detection of ligand binding proteins and rapid sorting of libraries derived from mixed population of organisms |
| 12/02/2004 | US20040241757 Membrane protein for use in identifying modulators for treatment and prevention neuronal trauma and disorders |
| 12/02/2004 | US20040241756 Methods and means of histone methylation |
| 12/02/2004 | US20040241755 Human cell assay to determine effect of sample compounds on Col2 enhancer expression |
| 12/02/2004 | US20040241754 Identifying modulators which intefere with association of ephrin receptor and its ligand or ephrin and postsynaptic density disc-large zo-1 protein (PDZ) for use in treatment of neurodegenerative diseases |
| 12/02/2004 | US20040241752 Point of care diagnostic systems |
| 12/02/2004 | US20040241751 Silicon substrate covered with organic thin film (self-assembled titanium oxide monolayer), with patches containing capture agent (antibodies) for immobilization of expression products, fragments, or cells; proteomics; bacteriophages; libraries; solid phase synthesis |
| 12/02/2004 | US20040241750 Novel methods for determining the negative control value for multi-analyte assays |
| 12/02/2004 | US20040241748 Self-assembling arrays and uses thereof |
| 12/02/2004 | US20040241744 Method of quantifying denatured lipoprotein, reagents for quantifying denatured lipoprotein, method of detecting circulatory disease and reagents for detecting circulatory disease |
| 12/02/2004 | US20040241742 Ligand array processing methods that include a low surface tension fluid deposition step and compositions for practicing the same |
| 12/02/2004 | US20040241741 Identifying unknown proteins based on mass, isoelectric point and amount per molecule of at least one amino acid type; proteomics |
| 12/02/2004 | US20040241738 Detection of binding reactions using labels detected by mediated catalytic electrochemistry |
| 12/02/2004 | US20040241736 Using spectrum analysis to determine blood glucose levels; diagnosing metabolic disorders |
| 12/02/2004 | US20040241733 High throughput screening assay systems in microscale fluidic devices |
| 12/02/2004 | US20040241731 Methods of producing nucleic acid ligands |
| 12/02/2004 | US20040241730 Visualizing expression data on chromosomal graphic schemes |
| 12/02/2004 | US20040241725 Lung cancer detection |
| 12/02/2004 | US20040241724 Immobilization method and kit therefor |
| 12/02/2004 | US20040241719 Nucleic acid sequence analysis |
| 12/02/2004 | US20040241714 Methods of assessment of drug metabolizing enzymes |
| 12/02/2004 | US20040241712 Diagnostic detection of nucleic acids |
| 12/02/2004 | US20040241711 a first specific binding pair (sbp) member capable of binding to the analyte or to a second sbp member to form a complex related to the presence of said analyte, sbp members is bound to a polymer, dispersed in a dopant activating chemiluminescent substance, determining effect of activation |
| 12/02/2004 | US20040241710 Methods of detecting colorectal cancer |
| 12/02/2004 | US20040241707 Enhanced diagnostic potential of prostate-specific antigen expressing cells |
| 12/02/2004 | US20040241700 Calibrating microarrays |
| 12/02/2004 | US20040241698 Extracting actinomycetes nucleotide sequences from soil and identifying biocatalytic nucleotide sequences; for use as tools in genetic engineering |
| 12/02/2004 | US20040241694 Using expression patter of neurodegenerative marker to diagnose/prognose brain disorders |
| 12/02/2004 | US20040241690 Method of evaluating biocompatibility |
| 12/02/2004 | US20040241688 Using tissue cartridges comprising tissue samples as tool for screening efficacy of drugs; bioreactors and drug screening |
| 12/02/2004 | US20040241685 Method of analyzing nucleic acid specifying gene showing change in expression dose in schizophrenia |
| 12/02/2004 | US20040241682 Cancer |
| 12/02/2004 | US20040241680 Method of determining endometrial status by tests applied on endometrial menstruation tissue (period tissue) |
| 12/02/2004 | US20040241679 Amplifying target sequence in presence of duplex binding agent, polymerase and labeled primer/probe, recovering product and monitoring fluorescence; kits |
| 12/02/2004 | US20040241675 Method and device for determining and selecting molecule-molecule interactions |
| 12/02/2004 | US20040241671 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their us as medicines |
| 12/02/2004 | US20040241670 Method and system for partitioning pixels in a scanned image of a microarray into a set of feature pixels and a set of background pixels |
| 12/02/2004 | US20040241669 Using image analysis to identify regions of biopolymer hybridization or interaction along a microarray; genomics and gene expression analysis |
| 12/02/2004 | US20040241665 Preparing microarray using pulse-jet fluid deposition of mixture which comprises nucleoside monomer and weak tetrazole acid onto solid support; genomic analysis; bioparticle quantification |
| 12/02/2004 | US20040241664 Protein Hydrolysates Enriched In Peptides Having A Carboxy Terminal Proline Residue |
| 12/02/2004 | US20040241662 Detecting microbial contamination in grain and related products |
| 12/02/2004 | US20040241661 Using differential labeling and colorimetric analysis to determine concentration of analytes sample; bioassay for use in gene expression analysis, DNA sequencing, mutation detection, genomics and proteomics |
| 12/02/2004 | US20040241658 Comparative genomic hybridiztion assays using immobilized oligonucleotide targets with initially small sample sizes and compositions for practicing the same |
| 12/02/2004 | US20040241653 Methods for identifying marker genes for cancer |
| 12/02/2004 | US20040241650 Computer-directed assembly of a polynucleotide encoding a target polypeptide |
| 12/02/2004 | US20040241643 Oligonucleotides for detecting infection of human blood; microarrays and disease diagnosis |
| 12/02/2004 | US20040241642 Polynucleotide fragments of an infections human endogenous retrovirus |
| 12/02/2004 | US20040241641 Monoclonal antibody for prevention and treatment of human immunodeficiency viral infection; immunotherapy |
| 12/02/2004 | US20040241637 Method for establishing a standardized detection system for identifying a microorganism |
| 12/02/2004 | US20040241636 Characterizing gene/protein function using high throughput assays; elucidation of biosynthetic pathways |
| 12/02/2004 | US20040241462 organic polymer linker material layer for enhancing the bond between a gold thin layer and a substrate; terminal end of polymer linker material is capable of reacting with substrate and the other end has positive charge capable of interaction with a negative charge of gold colloid |
| 12/02/2004 | US20040241428 Magnetic particles |
| 12/02/2004 | US20040241226 Administering a tyrosine kinase inhibitor, more particularly a non toxic, potent and selective c-kit inhibitor, wherein said inhibitor is unable to promote death of IL-3 dependent cells cultured to presence of IL-3 |
| 12/02/2004 | US20040241205 capsules comprising biocompatible silica sol-gel matrices that encapsulate chemical intermediates or prodrugs that convert when contacted with tissues and/or fluids; grafting encapsulated L-amino acid decarboxylase in the brain to convert L-dopa to dopamine for prophylaxis of Parkinson's disease |
| 12/02/2004 | US20040241180 Notch |
| 12/02/2004 | US20040241176 Method of producing membrane vesicles |
| 12/02/2004 | US20040241169 Administering antibodies, CD antigens to induce diarrhea, enterocolitis, dermatitis, hypophysitis, panhypopituitarism, rash, pruritis, dermatitis, vitiligo, and enterocolitis; cancer treatment |
| 12/02/2004 | US20040241167 CD4/CD25 antigen containing cell, interleukin, CD8/CD28 antigen containing cell, and vitamin D3; for generating tolerogenic antigen-presenting cell; kits; for treatment of autoimmune diseases such as AIDS, cancer, and Hepatitis C-related disorders |
| 12/02/2004 | US20040241166 Use of inhibitors of ikk-beta and method for discovery of said inhibitors |